CVE:SQD SQI Diagnostics (SQD) Stock Forecast, Price & News C$0.02 0.00 (0.00%) (As of 06/14/2023) Add Compare Share Share Today's RangeC$0.02▼C$0.0250-Day RangeC$0.02▼C$0.0252-Week RangeC$0.01▼C$0.18Volume65,000 shsAverage Volume172,133 shsMarket CapitalizationC$6.11 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsInsider TradesHeadlinesProfileChartCompetitorsEarningsInsider TradesHeadlines About SQI Diagnostics (CVE:SQD) StockSQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow. The company was founded in 1999 and is headquartered in Toronto, Canada.Read More SQD Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SQD Stock News HeadlinesJune 16, 2023 | finance.yahoo.comSQI Diagnostics Announces Receipt of Intention to Enforce Security from Pivot Financial and Anticipated Voluntary Bankruptcy FilingJune 6, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - SQDOctober 2, 2023 | Edge On The Street (Ad)Gold Could Be Heading for Record Highs - But How to Play It?According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold. May 18, 2023 | finance.yahoo.comThis SQI Diagnostics Insider Increased Their Holding In The Last YearMay 17, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc flat on Friday (SQD)April 29, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc up on Friday (SQD)April 27, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc up on Wednesday (SQD)April 25, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc down on Monday (SQD)October 2, 2023 | Edge On The Street (Ad)Gold Could Be Heading for Record Highs - But How to Play It?According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold. April 21, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc down on Thursday (SQD)April 15, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc down on Friday (SQD)April 12, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc flat on Wednesday (SQD)April 11, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc flat on Tuesday (SQD)March 20, 2023 | finance.yahoo.comSQI DIAGNOSTICS ANNOUNCES ISSUANCE OF PREVIOUSLY ANNOUNCED BONUS WARRANTSFebruary 6, 2023 | ca.finance.yahoo.comSQI DIAGNOSTICS EXTENDS MATURITY DATE OF PIVOT CREDIT FACILITY AND DEFERRAL OF CERTAIN INTEREST PAYMENTSDecember 9, 2022 | finance.yahoo.comThe Independent Director of SQI Diagnostics Inc. (CVE:SQD), Gerald Connor, Just Bought 5.8% More SharesOctober 19, 2022 | finance.yahoo.comSQI DIAGNOSTICS EXTENDS MATURITY DATE OF PIVOT CREDIT FACILITY AND ANNOUNCES DEFERRAL OF CERTAIN INTEREST PAYMENTSSeptember 19, 2022 | theglobeandmail.comSQI Diagnostics: Top 10 Undervalued Medical Diagnostics & Research Industry Sector Stocks on TSX Venture Exchange (SQD)August 30, 2022 | seekingalpha.comSQI Diagnostics reports Q3 resultsMarch 3, 2022 | finance.yahoo.comNew York State Approves SQI Diagnostics' EXACT COVID-19 Antibody AssayFebruary 9, 2022 | finance.yahoo.comSQI DIAGNOSTICS PROVIDES UPDATE ON PREVIOUSLY ANNOUNCED ASSET PURCHASE TRANSACTION WITH PBI DIAGNOSTICSJanuary 31, 2022 | ca.finance.yahoo.comStocks in play: SQI Diagnostics IncNovember 6, 2021 | yahoo.comWilmot Matthews Is The Non-Independent Director of SQI Diagnostics Inc. (CVE:SQD) And They Just Picked Up 8.1% More SharesAugust 18, 2021 | markets.businessinsider.comSQI Diagnostics Reports Third Quarter 2021 ResultsJuly 23, 2021 | stockhouse.comFDA Stops Emergency Use Authorization Review of SQI Diagnostics RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 PatientsFebruary 18, 2021 | prnewswire.comSQI Diagnostics Announces New Corporate WebsiteFebruary 10, 2021 | markets.businessinsider.comSQI Diagnostics Announces Proposed Insider Sales and Warrant Exercises to Fund CompanySee More Headlines Receive SQD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SQI Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address SQD Company Calendar Today10/01/2023Next Earnings (Estimated)10/02/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolCVE:SQD CUSIPN/A CIKN/A Websqidiagnostics.com Phone+1-416-6749500FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-19,140,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-74.70% Debt Debt-to-Equity Ratio464.33 Current Ratio0.12 Quick Ratio0.40 Sales & Book Value Annual SalesC$3.04 million Price / Sales2.01 Cash FlowC$0.00 per share Price / Cash Flow8.50 Book ValueC($0.04) per share Price / Book-0.38Miscellaneous Outstanding Shares407,170,000Free FloatN/AMarket CapC$6.11 million OptionableNot Optionable Beta0.07 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Andrew Morris (Age 57)Advisor to the Board & CEO Mr. Morlan Reddock C.F.A.CPA, CGA, M.B.A., CFO & VP of Admin.Dr. Eric Brouwer Ph.D. (Age 54)Chief Scientific Officer & Advisor to the Board Comp: $350kDr. Peter Lea Ph.D. (Age 78)Founder Mr. Tim McGoughChief Commercial OfficerKey Competitors3D SignaturesCVE:DXDLexaGeneCVE:LXGLED Medical DiagnosticsCVE:LMDAkuminTSE:AKUEntourage HealthCVE:ENTGView All CompetitorsInsidersGerald R. ConnorSold 3,800 sharesTotal: C$323.00 ($0.09/share)Clive BeddoeSold 12,000 sharesTotal: C$1,176.00 ($0.10/share)View All Insider Transactions SQD Stock - Frequently Asked Questions How have SQD shares performed in 2023? SQI Diagnostics' stock was trading at C$0.12 at the start of the year. Since then, SQD stock has decreased by 87.5% and is now trading at C$0.02. View the best growth stocks for 2023 here. When is SQI Diagnostics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, October 2nd 2023. View our SQD earnings forecast. What other stocks do shareholders of SQI Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some companies that other SQI Diagnostics investors own include The Cigna Group (CI), Global Payments (GPN), Alarm.com (ALRM), Baxter International (BAX), Becton, Dickinson and Company (BDX), Charter Communications (CHTR), Costco Wholesale (COST), Canadian Tire (CTC.A) and LadRx (CYTR). What is SQI Diagnostics' stock symbol? SQI Diagnostics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SQD." How do I buy shares of SQI Diagnostics? Shares of SQD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is SQI Diagnostics' stock price today? One share of SQD stock can currently be purchased for approximately C$0.02. How much money does SQI Diagnostics make? SQI Diagnostics (CVE:SQD) has a market capitalization of C$6.11 million and generates C$3.04 million in revenue each year. The company earns C$-19,140,000.00 in net income (profit) each year or C($0.05) on an earnings per share basis. How many employees does SQI Diagnostics have? The company employs 147,000 workers across the globe. How can I contact SQI Diagnostics? SQI Diagnostics' mailing address is 36 Meteor Dr, ETOBICOKE, ON M9W 1A4, Canada. The official website for the company is sqidiagnostics.com. The company can be reached via phone at +1-416-6749500. This page (CVE:SQD) was last updated on 10/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SQI Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.